“Things Are Going to Be Messed Up”
Need housing market predictions? We’ve got them. Unfortunately, they may not be exactly what you want to hear. While most landlords hope and pray that mortgage rates will head down…
Top 6 Challenges Faced by the Automotive Industry: The Post-COVID-19 Era
With successful vaccination drives slowly making the dreaded COVID-19 a thing of the past, nations worldwide have started putting more efforts towards recovering from the economic slump it created. In…
BOJ Sends Yields Soaring With Surprise Change to Rate Ceiling
(Bloomberg) -- The Bank of Japan jolted financial markets by loosening its grip on bond yields in Governor Kazuo Ueda’s first surprise move since taking the helm, a step that…
Bitcoin ETFs’ arrival is unlikely to trigger the crypto’s further rally. Here’s why
Welcome back! This is Frances Yue, reporter at MarketWatch. Crypto investors have long been hoping that an exchange-traded fund investing directly in bitcoin could boost adoption of the cryptocurrency and…
Analysis-How the ghost of 1990s property crash returned to haunt Sweden By Reuters
© Reuters. FILE PHOTO: A general view of central Stockholm, July 14, 2023. REUTERS/Tom Little/File Photo By John O'Donnell FRANKFURT (Reuters) - Long before Europe faced its debt crisis, Sweden…
The Fed’s “Time of Testing”: Is This Where the Trouble Will Stop?
“This is a time of testing — a testing not only of our capacity collectively to reach coherent and intelligent policies, but to stick with them.” — Paul Volcker, 9…
The Thriving Market for Electric Vehicles in Last Mile Delivery
Consumer purchasing habits have changed significantly because of the pandemic, and many of us now consider online shopping to be the default option. To address and satisfy the enormous demand…
Occidental College ends legacy admissions
Occidental College, a private liberal arts school in Los Angeles, is the latest school to end legacy admissions in the wake of a Supreme Court decision removing race from college admissions decisions. A campus…
AstraZeneca to buy Pfizer’s rare disease gene therapy portfolio for up to $1 billion By Reuters
2/2 © Reuters. FILE PHOTO-Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo 2/2 (Reuters) -AstraZeneca said on…
